耳鼻咽喉科・頭頸部外科89巻10号

2017年09月発行

特集 レーザー治療の最前線—コツとピットフォール 《食道・頭頸部領域》

食道がんに対する光線力学的療法（PDT）

著者： 角嶋直美¹ 滝沢耕平¹ 田中雅樹¹ 川田登¹ 吉田将雄¹ 小野裕之¹

所属機関： ¹静岡県立静岡がんセンター内視鏡科

ページ範囲：P.830 - P.836

POINT

●食道がん化学放射線療法（CRT）後の局所遺残再発病変の治療において，遠隔転移がなければsalvage外科治療だけでなく，salvage内視鏡治療が適応となる症例がある。

●食道がんCRT後の局所遺残再発病変に対するレザフィリン^®およびPDレーザを用いたsalvage PDTは有望な治療法である。

参考文献

1）Tachimori Y, et al：Comprehensive registry of esophageal cancer in Japan, 2009. Esophagus 13：110-137, 2016

2）Hironaka S, et al：Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T（2-3）N（any）M（0）squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 57：425-433, 2003

3）Kato K, et al：Phase Ⅱ study of chemoradiotherapy with 5-fluorouracil and cisplatic for Stage Ⅱ-Ⅲ esophageal squamous cell carcinoma：JCOG trial（JCOG9906）. Int J Radiat Oncol Biol Phys 81：684-690, 2011

4）Ishikura S, et al：Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 21：2697-2702, 2003

5）Nishimura M, et al：Salvage esophagectomy following definitive chemoradiotherapy. Gen Thorac Cardiovasc Surg 55：461-464, 2007

6）Tachimori Y, et al：Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 137：49-54, 2009

7）Miyata H, et al：Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer. J Surg Oncol 100：442-446, 2009

8）Morita M, et al：Clinical significance of salvage esophagectomy for remnant or recurrent cancer following definitive chemoradiotherapy. J Gastroenterol 46：1284-1291, 2011

9）Yano T, et al：Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Endoscopy 40：717-721, 2008

10）McMahon KS, et al：Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessel constriction, vessel leakage, and tumor response. Cancer Res 54：5374-5379, 1994

11）Gollnick SO, et al：Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer 88：1772-1779, 2003

12）Dougherty TJ, et al：Photoradiation therapy for the treatment of malignant tumors. Cancer Res 38：2628-2635, 1978

13）Yano T, et al：Long-term results of salvage photodynamic therapy for patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma. Endoscopy 43：657-663, 2011

14）Ohashi S, et al：Preclinical validation of talaporfin sodium-mediated photodynamic therapy for esophageal squamous cell carcinoma. PLoS One 9：e103126, 2014

15）Horimatsu T, et al：Tissue damage in the canine normal esophagus by photoactivation with talaporfin sodium（laserphyrin）：a preclinical study. PloS One 7：e38308, 2012

16）Yano T, et al：Phase Ⅰ study of photodynamic therapy using talaporfin sodium and diode laser for local failure after chemoradiotherapy for esophageal cancer. Radiat Oncol 7：113, 2012

17）Yano T, et al：A multicenter phase Ⅱ study of salvage photodynamic therapy using talaporfin sodium（ME2906）and a diode lase（PNL6405EPG）for local failure after chemoradiotherapy or radiotherapy for esophageal cancer. Oncotarget 8：22135-22144, 2017

18）Yamamoto S, et al：Endoscopic classification of local recurrence after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Esophagus 6：243, 2009

19）Tu CH, et al：Submucosal tumor appearance is a useful endoscopic predictor of early primary-site recurrence after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Dis Esophagus 24：274-278, 2011